GlassScriptPhysician profile
Stephanie Kaiser
NPI 1689033722
$4,448.03
in general payments reported to CMS, 2019-2025
16 companies · $2,021 in 2025
The $2,021 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $99.99 · 2023: $87.09 · 2024: $2,026 · 2025: $2,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,026 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,025.90 |
| Education | $108.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $827.54 | 2023-2025 | |
| Ucb, INC. | $748.91 | 2024-2025 | Bimzelx |
| Abbvie INC. | $545.32 | 2023-2025 | |
| Lilly USA, LLC | $346.72 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $329.18 | 2023-2025 | Sotyktu |
| Organon LLC | $287.41 | 2025 | Vtama |
| Regeneron Healthcare Solutions, INC. | $280.59 | 2024-2025 | Dupixent |
| Dermavant Sciences, INC. | $280.27 | 2023-2024 | Vtama |
| Galderma Laboratories, L.P. | $222.99 | 2024-2025 | Nemluvio |
| Janssen Biotech, INC. | $212.39 | 2022-2025 | Tremfya |
| Janssen Scientific Affairs, LLC | $121.93 | 2025 | Tremfya |
| Genzyme Corporation | $105.34 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $64.00 | 2024-2025 | |
| Incyte Corporation | $44.07 | 2024-2025 | Opzelura, Opzelura |
| Arcutis Biotherapeutics, INC. | $17.85 | 2024 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $13.52 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.